Anders Schack

Dr. Anders Schack

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Cell Reports
Verified
Journal Article
Open access
VLViktor Karlovich Lund
Viktor Karlovich Lund
MLMatthew Domenic Lycas
Matthew Domenic Lycas
ASAnders Schack
Anders Schack
RARita Chan Andersen
Rita Chan Andersen
UGUlrik Gether
Ulrik Gether
OKOle Kjaerulff
Ole Kjaerulff
Fast axonal transport of neuropeptide-containing dense core vesicles (DCVs), endolysosomal organelles, and presynaptic components is critical for maintaining neuronal functionality. How the transport of DCVs is orchestrated remains an important unresolved question. The small GTPase Rab2 mediates DCV biogenesis and endosome-lysosome fusion. Here, we use Drosophila to demonstrate that Rab2 also plays a critical role in bidirectional axonal transport of DCVs, endosomes, and lysosomal organelles, most likely by controlling molecular motors. We further show that the lysosomal motility factor Arl8 is required as well for axonal transport of DCVs, but unlike Rab2, it is also critical for DCV exit from cell bodies into axons. We also provide evidence that the upstream regulators of Rab2 and Arl8, Ema and BORC, activate these GTPases during DCV transport. Our results uncover the mechanisms underlying axonal transport of DCVs and reveal surprising parallels between the regulation of DCV and lysosomal motility.



1 April 2021 in Clinical Nutrition
Verified
Journal Article
Closed access
JBJakob Burcharth
Jakob Burcharth
AFAndreas Falkenberg
Andreas Falkenberg
ASAnders Schack
Anders Schack
SESarah Ekeloef
Sarah Ekeloef
Ismail GögenurIsmail Gögenur
Ismail Gögenur

27 March 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
ASAnders Schack
Anders Schack
JAJan Saip Aunan-Diop
Jan Saip Aunan-Diop
FGFrederik A. Gerhardt
Frederik A. Gerhardt
CPChristian Bonde Pedersen
Christian Bonde Pedersen
BHBo Halle
Bo Halle
FPFrantz Rom Poulsen
Frantz Rom Poulsen
Differentiating recurrent cerebral metastasis (CM) from brain radiation necrosis (BRN) is pivotal for guiding appropriate treatment and prognostication. Despite advances in imaging techniques, however, accurately distinguishing these conditions non-invasively is still challenging. This single-center retrospective study reviewed 32 cases (28 patients) with confirmed cerebral metastases who underwent surgical excision of lesions initially diagnosed by MRI and/or MR perfusion scans from 1 January 2015 to 30 September 2020. Diagnostic accuracy was assessed by comparing imaging findings with postoperative histopathology. Conventional MRI accurately identified recurrent CM in 75% of cases. MR perfusion scans showed significantly higher mean maximum relative cerebral blood volume (max. rCBV) in metastasis cases, indicating its potential as a discriminative biomarker. No single imaging modality could definitively distinguish CM from BRN. Survival analysis revealed gender as the only significant factor affecting overall survival, with no significant survival difference observed between patients with CM and BRN after controlling for confounding factors. This study underscores the limitations of both conventional MRI and MR perfusion scans in differentiating recurrent CM from BRN. Histopathological examination remains essential for accurate diagnosis. Further research is needed to improve the reliability of non-invasive imaging and to guide the management of patients with these post-radiation events.

2 January 2021 in European Journal of Trauma and Emergency Surgery
Verified
Journal Article
Closed access
PDF file
ASAnders Schack
Anders Schack
SESarah Ekeloef
Sarah Ekeloef
SOSisse Rye Ostrowski
Sisse Rye Ostrowski
IGIsmail Gögenur
Ismail Gögenur
JBJakob Burcharth
Jakob Burcharth